FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer

BACKGROUND: Bladder cancer is a common disease worldwide with most patients presenting with the non-muscle-invasive form (NMIBC) at initial diagnosis. Postoperational intravesical instillation of BCG is carried out for patients with high-risk disease to reduce tumor recurrence and progression to mus...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yang, Huo, Fan, Cao, Qiang, Jia, Ru, Huang, Qiju, Wang, Zhu A, Theodorescu, Dan, Lv, Qiang, Li, Pengchao, Yan, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971803/
https://www.ncbi.nlm.nih.gov/pubmed/35361729
http://dx.doi.org/10.1136/jitc-2021-003939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971803/
https://www.ncbi.nlm.nih.gov/pubmed/35361729
http://dx.doi.org/10.1136/jitc-2021-003939

Ejemplares similares